Nuvalent, Inc. (NUVL): Price and Financial Metrics

Nuvalent, Inc. (NUVL): $89.22

0.73 (+0.82%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add NUVL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#275 of 328

in industry

NUVL Price/Volume Stats

Current price $89.22 52-week high $113.51
Prev. close $88.49 52-week low $54.37
Day low $87.25 Volume 755,700
Day high $91.31 Avg. volume 441,163
50-day MA $95.89 Dividend yield N/A
200-day MA $80.69 Market Cap 5.78B

NUVL Stock Price Chart Interactive Chart >


Nuvalent, Inc. (NUVL) Company Bio


Nuvalent, Inc., a preclinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor, designed to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and also remain active in the presence of mutations conferring resistance to approved and investigational ROS1 inhibitors; and NVL-655, a brain-penetrant ALK-selective inhibitor, designed to inhibit ALK fusions that express the normal ALK kinase domain without any drug-resistant mutations and also remain active in the presence of mutations conferring resistance to first, second, and third generation ALK inhibitors. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.


NUVL Latest News Stream


Event/Time News Detail
Loading, please wait...

NUVL Latest Social Stream


Loading social stream, please wait...

View Full NUVL Social Stream

NUVL Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!